Physician profile
Alexander K Eitel
NPI 1093739849
$1,484.41
in general payments reported to CMS, 2019-2025
11 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $35.00 · 2021: $16.05 · 2022: $268 · 2023: $594 · 2024: $303 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,025.49 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.25 | 2024-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $62.25 | 2022-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.42 | 2019-2020 | |
| Janssen Biotech, INC. | $43.46 | 2024 | Stelara |
| Lilly USA, LLC | $42.01 | 2024-2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $41.63 | 2023-2024 | Ocaliva |
| Madrigal Pharmaceuticals | $23.36 | 2025 | Rezdiffra |
| Ardelyx, INC. | $23.34 | 2023 | Ibsrela |
| Accord Healthcare, INC. | $22.52 | 2025 | |
| Braintree Laboratories, INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Eitel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.